Alexei Basnakian
Concepts (365)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deoxyribonuclease I | 11 | 2020 | 34 | 3.620 |
Why?
| | Endodeoxyribonucleases | 11 | 2021 | 47 | 3.000 |
Why?
| | DNA Fragmentation | 12 | 2021 | 53 | 2.640 |
Why?
| | Apoptosis | 16 | 2021 | 1120 | 2.530 |
Why?
| | Lipoproteins, LDL | 13 | 2014 | 177 | 2.450 |
Why?
| | Kidney Tubules | 8 | 2020 | 63 | 1.880 |
Why?
| | Epithelial Cells | 8 | 2020 | 217 | 1.650 |
Why?
| | Atherosclerosis | 8 | 2015 | 224 | 1.350 |
Why?
| | Kidney Diseases | 4 | 2021 | 230 | 1.270 |
Why?
| | In Situ Nick-End Labeling | 5 | 2021 | 54 | 1.030 |
Why?
| | Animals | 46 | 2025 | 13485 | 0.960 |
Why?
| | Oxidative Stress | 6 | 2021 | 805 | 0.910 |
Why?
| | Endothelium, Vascular | 4 | 2014 | 263 | 0.870 |
Why?
| | Kidney | 7 | 2025 | 716 | 0.850 |
Why?
| | Deoxyribonucleases | 3 | 2021 | 23 | 0.800 |
Why?
| | Enzyme Inhibitors | 6 | 2017 | 378 | 0.710 |
Why?
| | DNA Topoisomerases | 1 | 2021 | 3 | 0.710 |
Why?
| | DNA | 5 | 2020 | 544 | 0.700 |
Why?
| | DNA Breaks | 1 | 2020 | 3 | 0.680 |
Why?
| | Cisplatin | 6 | 2025 | 282 | 0.680 |
Why?
| | DNA Damage | 4 | 2021 | 298 | 0.670 |
Why?
| | Cell Line | 10 | 2021 | 1020 | 0.670 |
Why?
| | DNA Repair | 1 | 2021 | 194 | 0.640 |
Why?
| | Endothelial Cells | 4 | 2010 | 283 | 0.610 |
Why?
| | Rats | 13 | 2020 | 3228 | 0.610 |
Why?
| | Cells, Cultured | 12 | 2021 | 1583 | 0.610 |
Why?
| | Chromatin | 3 | 2007 | 143 | 0.540 |
Why?
| | Small Molecule Libraries | 2 | 2014 | 66 | 0.540 |
Why?
| | Mice | 22 | 2025 | 5899 | 0.530 |
Why?
| | Graphite | 1 | 2017 | 26 | 0.520 |
Why?
| | Antineoplastic Agents | 4 | 2014 | 1216 | 0.500 |
Why?
| | Nanoparticles | 1 | 2017 | 131 | 0.480 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2015 | 180 | 0.460 |
Why?
| | Intercellular Adhesion Molecule-1 | 4 | 2020 | 59 | 0.450 |
Why?
| | Enzyme Assays | 1 | 2014 | 10 | 0.450 |
Why?
| | High-Throughput Screening Assays | 1 | 2014 | 39 | 0.440 |
Why?
| | Macrophages | 2 | 2014 | 357 | 0.430 |
Why?
| | Uremia | 2 | 2010 | 13 | 0.420 |
Why?
| | Mice, Knockout | 10 | 2025 | 903 | 0.410 |
Why?
| | Carbamates | 1 | 2013 | 15 | 0.410 |
Why?
| | Acetylcysteine | 2 | 2013 | 101 | 0.410 |
Why?
| | Acute Kidney Injury | 3 | 2025 | 389 | 0.400 |
Why?
| | Monocytes | 3 | 2010 | 124 | 0.400 |
Why?
| | Organ Preservation | 1 | 2013 | 33 | 0.390 |
Why?
| | Cell Death | 7 | 2015 | 169 | 0.380 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2025 | 208 | 0.360 |
Why?
| | Endonucleases | 4 | 2021 | 14 | 0.340 |
Why?
| | Humans | 34 | 2025 | 52441 | 0.330 |
Why?
| | Liver Neoplasms | 2 | 2025 | 341 | 0.330 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 2 | 2008 | 38 | 0.330 |
Why?
| | Nucleic Acids | 1 | 2009 | 14 | 0.310 |
Why?
| | Receptors, Scavenger | 1 | 2009 | 29 | 0.310 |
Why?
| | Gamma Rays | 1 | 2009 | 48 | 0.310 |
Why?
| | Disease Models, Animal | 9 | 2025 | 1483 | 0.300 |
Why?
| | Enzyme Activation | 5 | 2015 | 269 | 0.300 |
Why?
| | Cell Line, Tumor | 7 | 2025 | 1429 | 0.300 |
Why?
| | Mice, Inbred C57BL | 7 | 2025 | 1888 | 0.300 |
Why?
| | DNA Methylation | 2 | 2014 | 573 | 0.290 |
Why?
| | Nerve Growth Factors | 1 | 2008 | 26 | 0.280 |
Why?
| | Cadmium Chloride | 1 | 2007 | 3 | 0.270 |
Why?
| | DNA Replication | 2 | 2009 | 159 | 0.260 |
Why?
| | Oxidoreductases | 2 | 2004 | 56 | 0.260 |
Why?
| | Tumor Suppressor Proteins | 1 | 2008 | 127 | 0.260 |
Why?
| | Chromosomes | 2 | 2006 | 29 | 0.260 |
Why?
| | Drosophila melanogaster | 1 | 2007 | 33 | 0.260 |
Why?
| | Cell Nucleus | 2 | 2007 | 189 | 0.260 |
Why?
| | B-Lymphocytes | 1 | 2007 | 178 | 0.250 |
Why?
| | Mammals | 1 | 2006 | 59 | 0.250 |
Why?
| | Promoter Regions, Genetic | 1 | 2008 | 465 | 0.240 |
Why?
| | RNA, Messenger | 2 | 2015 | 1134 | 0.230 |
Why?
| | Cell Movement | 1 | 2006 | 271 | 0.230 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 1 | 2025 | 16 | 0.230 |
Why?
| | Ischemia | 2 | 2004 | 150 | 0.220 |
Why?
| | Coronary Vessels | 5 | 2011 | 169 | 0.220 |
Why?
| | Focal Adhesion Kinase 2 | 1 | 2024 | 17 | 0.220 |
Why?
| | Reperfusion Injury | 2 | 2002 | 73 | 0.220 |
Why?
| | Prostatic Neoplasms | 1 | 2008 | 398 | 0.220 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 234 | 0.220 |
Why?
| | Cell Adhesion | 3 | 2010 | 162 | 0.220 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 853 | 0.210 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2017 | 1365 | 0.210 |
Why?
| | Signal Transduction | 6 | 2021 | 1724 | 0.210 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 257 | 0.200 |
Why?
| | Osteoporosis | 1 | 2024 | 157 | 0.200 |
Why?
| | Oncolytic Virotherapy | 1 | 2022 | 19 | 0.190 |
Why?
| | Kidney Failure, Chronic | 4 | 2012 | 205 | 0.190 |
Why?
| | Glucocorticoids | 1 | 2024 | 234 | 0.190 |
Why?
| | Breast Neoplasms | 2 | 2014 | 1203 | 0.190 |
Why?
| | Kidney Cortex | 1 | 2002 | 23 | 0.190 |
Why?
| | Acute Radiation Syndrome | 1 | 2022 | 12 | 0.190 |
Why?
| | Antioxidants | 2 | 2015 | 255 | 0.190 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2008 | 135 | 0.190 |
Why?
| | Chromans | 1 | 2022 | 34 | 0.180 |
Why?
| | Nanotubes, Carbon | 1 | 2022 | 43 | 0.180 |
Why?
| | Renal Circulation | 1 | 2002 | 56 | 0.180 |
Why?
| | Alternative Splicing | 1 | 2002 | 61 | 0.180 |
Why?
| | Radiation-Protective Agents | 1 | 2022 | 69 | 0.180 |
Why?
| | Vitamin E | 1 | 2022 | 77 | 0.180 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 580 | 0.170 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 83 | 0.170 |
Why?
| | Rats, Sprague-Dawley | 4 | 2013 | 1558 | 0.160 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2020 | 37 | 0.160 |
Why?
| | Thrombomodulin | 1 | 2020 | 26 | 0.160 |
Why?
| | Caspases | 3 | 2013 | 101 | 0.160 |
Why?
| | Cell Survival | 2 | 2014 | 598 | 0.160 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2020 | 83 | 0.160 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 102 | 0.160 |
Why?
| | Flow Cytometry | 2 | 2015 | 396 | 0.160 |
Why?
| | Hydrazones | 1 | 2019 | 6 | 0.150 |
Why?
| | Acinetobacter baumannii | 1 | 2019 | 12 | 0.150 |
Why?
| | Urea | 2 | 2010 | 80 | 0.150 |
Why?
| | Autophagy | 1 | 2021 | 185 | 0.150 |
Why?
| | Drug Resistance, Bacterial | 1 | 2019 | 75 | 0.150 |
Why?
| | Staphylococcus aureus | 2 | 2019 | 312 | 0.140 |
Why?
| | Molecular Structure | 2 | 2019 | 317 | 0.140 |
Why?
| | Male | 11 | 2025 | 26874 | 0.140 |
Why?
| | Brain | 2 | 2017 | 1337 | 0.140 |
Why?
| | RNA, Small Interfering | 2 | 2009 | 217 | 0.140 |
Why?
| | Etoposide | 2 | 2008 | 70 | 0.130 |
Why?
| | Microscopy, Fluorescence | 2 | 2009 | 140 | 0.130 |
Why?
| | Heme Oxygenase (Decyclizing) | 1 | 2017 | 7 | 0.130 |
Why?
| | Transfection | 2 | 2009 | 365 | 0.130 |
Why?
| | Profilins | 1 | 2017 | 13 | 0.130 |
Why?
| | Caspase 3 | 1 | 2017 | 91 | 0.130 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2017 | 56 | 0.130 |
Why?
| | Risk Assessment | 2 | 2022 | 1349 | 0.130 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2017 | 36 | 0.130 |
Why?
| | Time Factors | 2 | 2017 | 2987 | 0.130 |
Why?
| | Mutation, Missense | 1 | 2017 | 108 | 0.120 |
Why?
| | Gold | 2 | 2014 | 81 | 0.120 |
Why?
| | Liver | 3 | 2021 | 1150 | 0.120 |
Why?
| | Spinal Cord | 1 | 2017 | 169 | 0.120 |
Why?
| | Cell Cycle | 2 | 2007 | 236 | 0.120 |
Why?
| | Gene Knockout Techniques | 2 | 2021 | 50 | 0.120 |
Why?
| | Cell Culture Techniques | 2 | 2007 | 97 | 0.120 |
Why?
| | Cyclophilins | 1 | 2015 | 9 | 0.110 |
Why?
| | Enzyme Activators | 1 | 2015 | 8 | 0.110 |
Why?
| | Adenylate Kinase | 1 | 2015 | 10 | 0.110 |
Why?
| | Immunoenzyme Techniques | 1 | 2015 | 134 | 0.110 |
Why?
| | Antibodies | 3 | 2014 | 144 | 0.110 |
Why?
| | Taxoids | 1 | 2014 | 38 | 0.110 |
Why?
| | Thiobarbiturates | 1 | 2014 | 22 | 0.110 |
Why?
| | Inhibitory Concentration 50 | 1 | 2014 | 74 | 0.110 |
Why?
| | PPAR alpha | 1 | 2015 | 61 | 0.110 |
Why?
| | Risk Factors | 4 | 2015 | 3971 | 0.110 |
Why?
| | Drug Resistance | 1 | 2014 | 69 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 182 | 0.110 |
Why?
| | Cardiovascular Diseases | 2 | 2012 | 493 | 0.110 |
Why?
| | Substrate Specificity | 1 | 2014 | 197 | 0.110 |
Why?
| | Nanotubes | 1 | 2014 | 17 | 0.110 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2014 | 34 | 0.110 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2014 | 86 | 0.110 |
Why?
| | Silver | 1 | 2014 | 48 | 0.100 |
Why?
| | Blotting, Western | 1 | 2015 | 587 | 0.100 |
Why?
| | Particulate Matter | 1 | 2014 | 70 | 0.100 |
Why?
| | Zinc Acetate | 1 | 2013 | 1 | 0.100 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2015 | 234 | 0.100 |
Why?
| | Refrigeration | 1 | 2013 | 4 | 0.100 |
Why?
| | Organ Preservation Solutions | 1 | 2013 | 5 | 0.100 |
Why?
| | Metformin | 1 | 2015 | 82 | 0.100 |
Why?
| | Myocytes, Cardiac | 1 | 2015 | 146 | 0.100 |
Why?
| | Kinetics | 1 | 2014 | 613 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 816 | 0.100 |
Why?
| | Dietary Fats | 2 | 2010 | 134 | 0.100 |
Why?
| | Mitochondrial Membrane Transport Proteins | 2 | 2015 | 18 | 0.100 |
Why?
| | Carotenoids | 1 | 2012 | 24 | 0.100 |
Why?
| | Magnetite Nanoparticles | 1 | 2012 | 15 | 0.100 |
Why?
| | Oxidation-Reduction | 1 | 2013 | 327 | 0.090 |
Why?
| | Cell Division | 3 | 2008 | 288 | 0.090 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2015 | 198 | 0.090 |
Why?
| | Bacteremia | 1 | 2012 | 87 | 0.090 |
Why?
| | Cell Proliferation | 3 | 2010 | 1013 | 0.090 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2011 | 9 | 0.090 |
Why?
| | Genital Diseases, Female | 1 | 2011 | 18 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2014 | 1223 | 0.090 |
Why?
| | Chlamydia muridarum | 1 | 2011 | 39 | 0.090 |
Why?
| | Uterus | 1 | 2011 | 87 | 0.090 |
Why?
| | Liver Diseases, Alcoholic | 1 | 2010 | 35 | 0.080 |
Why?
| | Renal Dialysis | 3 | 2012 | 189 | 0.080 |
Why?
| | Chlamydia Infections | 1 | 2011 | 74 | 0.080 |
Why?
| | Epigenesis, Genetic | 1 | 2014 | 396 | 0.080 |
Why?
| | Nephrectomy | 1 | 2010 | 81 | 0.080 |
Why?
| | Apolipoproteins E | 1 | 2010 | 58 | 0.080 |
Why?
| | Salicylates | 1 | 2009 | 9 | 0.080 |
Why?
| | Scavenger Receptors, Class F | 1 | 2009 | 2 | 0.080 |
Why?
| | Staphylococcal Infections | 1 | 2012 | 270 | 0.080 |
Why?
| | Chelating Agents | 1 | 2009 | 31 | 0.080 |
Why?
| | Cell Line, Transformed | 1 | 2009 | 74 | 0.080 |
Why?
| | Blood Proteins | 1 | 2010 | 84 | 0.080 |
Why?
| | Inflammation | 1 | 2014 | 649 | 0.080 |
Why?
| | Green Fluorescent Proteins | 1 | 2009 | 85 | 0.080 |
Why?
| | DNA Polymerase III | 1 | 2009 | 5 | 0.080 |
Why?
| | Replication Protein C | 1 | 2009 | 5 | 0.080 |
Why?
| | Replication Protein A | 1 | 2009 | 6 | 0.080 |
Why?
| | Jejunum | 1 | 2009 | 54 | 0.080 |
Why?
| | Mice, Inbred Strains | 1 | 2009 | 165 | 0.080 |
Why?
| | Ileum | 1 | 2009 | 87 | 0.080 |
Why?
| | Fatty Liver | 1 | 2010 | 141 | 0.080 |
Why?
| | Zinc | 1 | 2009 | 57 | 0.080 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2009 | 68 | 0.080 |
Why?
| | Plasmids | 1 | 2009 | 162 | 0.080 |
Why?
| | Autoantibodies | 1 | 2010 | 118 | 0.080 |
Why?
| | CHO Cells | 2 | 2006 | 123 | 0.070 |
Why?
| | Cricetinae | 2 | 2006 | 189 | 0.070 |
Why?
| | Radiation Injuries, Experimental | 1 | 2009 | 80 | 0.070 |
Why?
| | Whole-Body Irradiation | 1 | 2009 | 128 | 0.070 |
Why?
| | Spleen | 1 | 2009 | 166 | 0.070 |
Why?
| | Oxidants | 2 | 2015 | 51 | 0.070 |
Why?
| | Lipids | 1 | 2009 | 163 | 0.070 |
Why?
| | RNA | 1 | 2009 | 174 | 0.070 |
Why?
| | Protein Kinase Inhibitors | 2 | 2024 | 231 | 0.070 |
Why?
| | Dependovirus | 1 | 2009 | 104 | 0.070 |
Why?
| | Ethanol | 1 | 2010 | 334 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2014 | 871 | 0.070 |
Why?
| | Chronic Disease | 1 | 2010 | 579 | 0.070 |
Why?
| | CpG Islands | 1 | 2008 | 111 | 0.070 |
Why?
| | Female | 7 | 2025 | 28277 | 0.070 |
Why?
| | Survival Analysis | 1 | 2009 | 656 | 0.070 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2008 | 95 | 0.070 |
Why?
| | Bone Marrow | 1 | 2009 | 354 | 0.070 |
Why?
| | Cytoprotection | 1 | 2007 | 32 | 0.070 |
Why?
| | Cell Size | 1 | 2007 | 45 | 0.070 |
Why?
| | Scavenger Receptors, Class E | 1 | 2009 | 200 | 0.070 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2007 | 53 | 0.070 |
Why?
| | Cell Count | 1 | 2007 | 143 | 0.070 |
Why?
| | Reactive Oxygen Species | 2 | 2015 | 415 | 0.070 |
Why?
| | Gene Silencing | 1 | 2007 | 122 | 0.070 |
Why?
| | Nucleosomes | 1 | 2007 | 12 | 0.070 |
Why?
| | Acute Disease | 1 | 2008 | 384 | 0.060 |
Why?
| | Camptothecin | 1 | 2006 | 14 | 0.060 |
Why?
| | K562 Cells | 1 | 2006 | 41 | 0.060 |
Why?
| | MAP Kinase Signaling System | 1 | 2006 | 128 | 0.060 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2009 | 299 | 0.060 |
Why?
| | Breast | 1 | 2006 | 86 | 0.060 |
Why?
| | CTLA-4 Antigen | 1 | 2025 | 32 | 0.060 |
Why?
| | Models, Molecular | 1 | 2007 | 356 | 0.060 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2025 | 46 | 0.060 |
Why?
| | Arteriosclerosis | 1 | 2005 | 49 | 0.060 |
Why?
| | Interphase | 1 | 2005 | 9 | 0.060 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2025 | 86 | 0.060 |
Why?
| | Biotin | 1 | 2005 | 46 | 0.060 |
Why?
| | Amides | 1 | 2024 | 36 | 0.060 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 140 | 0.060 |
Why?
| | Immunohistochemistry | 1 | 2007 | 977 | 0.060 |
Why?
| | Cell Hypoxia | 1 | 2004 | 82 | 0.050 |
Why?
| | Rabbits | 1 | 2005 | 370 | 0.050 |
Why?
| | Immunotherapy | 1 | 2025 | 251 | 0.050 |
Why?
| | Administration, Oral | 1 | 2024 | 455 | 0.050 |
Why?
| | Acetaminophen | 1 | 2006 | 272 | 0.050 |
Why?
| | Caspase Inhibitors | 1 | 2002 | 16 | 0.050 |
Why?
| | Glycerol | 1 | 2002 | 19 | 0.050 |
Why?
| | Gentamicins | 1 | 2002 | 32 | 0.050 |
Why?
| | Vesiculovirus | 1 | 2022 | 6 | 0.050 |
Why?
| | Coronary Artery Disease | 1 | 2006 | 323 | 0.050 |
Why?
| | Agriculture | 1 | 2022 | 18 | 0.050 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2002 | 48 | 0.050 |
Why?
| | Plants | 1 | 2022 | 28 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2025 | 938 | 0.050 |
Why?
| | Molecular Weight | 1 | 2002 | 78 | 0.050 |
Why?
| | Macaca mulatta | 1 | 2022 | 94 | 0.050 |
Why?
| | Ki-67 Antigen | 1 | 2022 | 57 | 0.050 |
Why?
| | Sequence Alignment | 1 | 2002 | 121 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2002 | 129 | 0.050 |
Why?
| | Nucleic Acid Conformation | 1 | 2002 | 84 | 0.050 |
Why?
| | Disease Progression | 1 | 2025 | 870 | 0.050 |
Why?
| | Cloning, Molecular | 1 | 2002 | 181 | 0.050 |
Why?
| | Fumonisins | 1 | 2001 | 5 | 0.050 |
Why?
| | Exons | 1 | 2002 | 101 | 0.050 |
Why?
| | Oxygen | 1 | 2004 | 332 | 0.050 |
Why?
| | Mitochondria, Heart | 2 | 2015 | 39 | 0.040 |
Why?
| | Cardiac Surgical Procedures | 1 | 2025 | 329 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2025 | 1045 | 0.040 |
Why?
| | Sequence Analysis, DNA | 1 | 2002 | 220 | 0.040 |
Why?
| | Class III Phosphatidylinositol 3-Kinases | 1 | 2021 | 1 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2001 | 122 | 0.040 |
Why?
| | Base Sequence | 1 | 2002 | 632 | 0.040 |
Why?
| | Drosophila | 1 | 2021 | 18 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2021 | 38 | 0.040 |
Why?
| | 14-3-3 Proteins | 1 | 2021 | 18 | 0.040 |
Why?
| | Intestines | 1 | 2022 | 159 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2002 | 778 | 0.040 |
Why?
| | Bone and Bones | 1 | 2024 | 492 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2002 | 375 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 7 | 1 | 2020 | 5 | 0.040 |
Why?
| | Radiation | 1 | 2020 | 14 | 0.040 |
Why?
| | Protein Biosynthesis | 1 | 2002 | 267 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2021 | 135 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2020 | 185 | 0.040 |
Why?
| | Prognosis | 1 | 2025 | 2100 | 0.040 |
Why?
| | Middle Aged | 2 | 2025 | 13133 | 0.040 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2019 | 21 | 0.040 |
Why?
| | Phosphorylation | 1 | 2021 | 536 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2019 | 271 | 0.040 |
Why?
| | Transcriptome | 1 | 2021 | 357 | 0.040 |
Why?
| | Mitochondria | 1 | 2021 | 420 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2017 | 79 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 1004 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2017 | 566 | 0.030 |
Why?
| | Pyrones | 1 | 2015 | 8 | 0.030 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2015 | 43 | 0.030 |
Why?
| | Biphenyl Compounds | 1 | 2015 | 32 | 0.030 |
Why?
| | Thiophenes | 1 | 2015 | 45 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2014 | 19 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2014 | 63 | 0.030 |
Why?
| | 5-Methylcytosine | 1 | 2014 | 16 | 0.030 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2014 | 64 | 0.030 |
Why?
| | Spectrum Analysis, Raman | 1 | 2014 | 42 | 0.030 |
Why?
| | Metal Nanoparticles | 1 | 2014 | 66 | 0.030 |
Why?
| | Protein Binding | 1 | 2015 | 673 | 0.020 |
Why?
| | Staphylococcal Protein A | 1 | 2012 | 5 | 0.020 |
Why?
| | Photochemical Processes | 1 | 2012 | 5 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2025 | 6694 | 0.020 |
Why?
| | Color | 1 | 2012 | 16 | 0.020 |
Why?
| | Photoacoustic Techniques | 1 | 2012 | 22 | 0.020 |
Why?
| | Molecular Imaging | 1 | 2012 | 28 | 0.020 |
Why?
| | Light | 1 | 2012 | 50 | 0.020 |
Why?
| | Complementary Therapies | 1 | 2012 | 23 | 0.020 |
Why?
| | Lasers | 1 | 2012 | 64 | 0.020 |
Why?
| | Lipoproteins | 1 | 2012 | 41 | 0.020 |
Why?
| | Mice, Nude | 1 | 2012 | 230 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 390 | 0.020 |
Why?
| | Hot Temperature | 1 | 2012 | 203 | 0.020 |
Why?
| | Interferon-beta | 1 | 2011 | 33 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 47 | 0.020 |
Why?
| | MAP Kinase Kinase 4 | 1 | 2011 | 30 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 48 | 0.020 |
Why?
| | Aged | 1 | 2025 | 10242 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2011 | 161 | 0.020 |
Why?
| | Hedgehog Proteins | 1 | 2010 | 33 | 0.020 |
Why?
| | Liver Regeneration | 1 | 2010 | 46 | 0.020 |
Why?
| | Models, Animal | 1 | 2011 | 230 | 0.020 |
Why?
| | Neoplasms | 1 | 2020 | 1314 | 0.020 |
Why?
| | Enteral Nutrition | 1 | 2010 | 154 | 0.020 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2010 | 191 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2010 | 189 | 0.020 |
Why?
| | RNA, Neoplasm | 1 | 2009 | 45 | 0.020 |
Why?
| | Parvoviridae Infections | 1 | 2009 | 19 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2011 | 318 | 0.020 |
Why?
| | Adult | 1 | 2005 | 14205 | 0.020 |
Why?
| | Keratinocytes | 1 | 2009 | 91 | 0.020 |
Why?
| | Cytokines | 1 | 2011 | 622 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2008 | 69 | 0.020 |
Why?
| | Apoptosis Inducing Factor | 1 | 2007 | 4 | 0.020 |
Why?
| | Virus Replication | 1 | 2009 | 147 | 0.020 |
Why?
| | Citrate (si)-Synthase | 1 | 2007 | 11 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 412 | 0.020 |
Why?
| | Gene Expression | 1 | 2009 | 618 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2007 | 193 | 0.020 |
Why?
| | NAD | 1 | 2006 | 46 | 0.020 |
Why?
| | Calcium | 1 | 2007 | 396 | 0.010 |
Why?
| | Necrosis | 1 | 2006 | 169 | 0.010 |
Why?
| | Cholesterol, LDL | 1 | 2005 | 42 | 0.010 |
Why?
| | Liver Diseases | 1 | 2006 | 81 | 0.010 |
Why?
| | Deoxyuracil Nucleotides | 1 | 2005 | 2 | 0.010 |
Why?
| | Biotinylation | 1 | 2005 | 28 | 0.010 |
Why?
| | Cell Membrane Permeability | 1 | 2005 | 24 | 0.010 |
Why?
| | Cricetulus | 1 | 2005 | 100 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 2006 | 234 | 0.010 |
Why?
| | Glutathione | 1 | 2006 | 301 | 0.010 |
Why?
| | LLC-PK1 Cells | 1 | 2001 | 10 | 0.010 |
Why?
| | Sphingomyelins | 1 | 2001 | 8 | 0.010 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2001 | 11 | 0.010 |
Why?
| | Carboxylic Acids | 1 | 2001 | 18 | 0.010 |
Why?
| | Ceramides | 1 | 2001 | 33 | 0.010 |
Why?
| | Swine | 1 | 2001 | 428 | 0.010 |
Why?
|
|
Basnakian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|